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Introduction: Recent experimental and clinical studies have indicated the cardioprotective role of sildenafil during
ischemia/reperfusion injury. The aim of this study was to determine, by obtaining metabolic evidence from microdialysis,
if sildenafil could reduce the severity of postresuscitation myocardial dysfunction and lead to cardioprotection through
beneficial effects on energy metabolism.
Methods: Twenty-four male piglets were randomly divided into three groups: sildenafil (n = 8), saline (SA; n = 8) and
sham operation (n = 8). Sildenafil pretreatment consisted of 0.5 mg/kg sildenafil administered once intraperitoneally
30 minutes prior to ventricular fibrillation (VF). The myocardial interstitial fluid (ISF) concentrations of glucose, lactate,
pyruvate, glutamate and glycerol were determined by microdialysis before VF. Afterward, the piglets were subjected to
8 minutes of untreated VF followed by 15 minutes of open-chest cardiopulmonary resuscitation. ISF was collected
continuously, and the experiment was terminated 24 hours after resuscitation.
Results: After 8 minutes of untreated VF, the sildenafil group exhibited higher glucose and pyruvate concentrations of ISF
and lower lactate and glutamate levels in comparison with the SA group, and these data reached statistical significance
(P < 0.05). Advanced cardiac life support was delivered to both groups, with a 24-hour survival rate showing a promising
trend in the sildenafil group (7 of 8 versus 3 of 8 survivors, P < 0.05). Compared with the SA group, the sildenafil group
had a better outcome in terms of hemodynamic and oxygen metabolism parameters (P < 0.05). Myocardial tissue analysis
revealed a dramatic increase in the contents of ATP, ADP and phosphocreatine in the sildenafil group versus
the SA group at 24 hours after return of spontaneous circulation (ROSC; P = 0.03, P = 0.02 and P = 0.02, respectively).
Furthermore, 24 hours after ROSC, the sildenafil group had marked elevations in activity of left ventricular Na+-K+-ATPase
and Ca2+-ATPase compared with the SA group (P = 0.03, P = 0.04, respectively).
Conclusions: Sildenafil could reduce the severity of postresuscitation myocardial dysfunction, and it produced better
clearance of metabolic waste in the ISF. This work might provide insights into the development of a novel strategy to
treat postresuscitation myocardial dysfunction.* Correspondence: lcscyyy@163.com
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Morbidity and mortality due to cardiac arrest (CA) remains
unacceptably high, yet effective treatments for CA have
proven to be elusive [1]. In patients who initially achieve
return of spontaneous circulation (ROSC) after CA, the
significant subsequent morbidity and mortality are largely
due to the myocardial dysfunction that accompanies
prolonged whole-body ischemia. Furthermore, CA con-
tributes to hemodynamic disorders that cause the systemic
release of massive oxygen free radicals, lactic acid and
metabolites of arachidonic acid, which could reach the
different tissues via blood circulation and could cause
ischemia/reperfusion (I/R) injury [2]. Postresuscitation
myocardial dysfunction, an important component of the
“post–cardiac arrest syndrome,” is caused by I/R injury and
includes primary manifestations such as arrhythmias, myo-
cyte apoptosis and contractile dysfunction [3]. In addition,
myocardial dysfunction aggravates persistent precipitating
pathologies, such as microcirculatory dysfunction, requiring
lifelong medication and clinical follow-up.
Nitric oxide (NO) has been identified as an important
mediator of the physiological and pathological processes
in I/R injury [4]. Sildenafil is a selective inhibitor of the
isoform 5 of the enzyme phosphodiesterase (PDE5),
which is responsible for the breakdown of 39,59-cyclic
guanosine monophosphate (cGMP) in smooth muscle
cells [5]. As the intracellular level of cGMP is controlled by
the activity of PDE5, it is expected that pharmacological
inhibition of PDE5 by sildenafil could improve cardiopro-
tection in the myocardium. As a pharmacological stimula-
tor of ischemic preconditioning, sildenafil now represents a
powerful therapeutic tool for treating several cardiovascular
disorders and provides direct cardioprotection against
ischemia through NO-dependent pathways [5,6]. Well-
tolerated for long-term treatment with few side effects,
sildenafil reduces pulmonary vascular resistance, improves
arterial oxygenation in patients with pulmonary artery
hypertension and prevents altitude-induced hypoxemia
[7,8]; however, the potential role of sildenafil as a novel
pharmacologic adjunct to resuscitation from CA for the
purpose of attenuating the myocardial dysfunction caused
by I/R injury remains unexplored.
The microdialysis technique is capable of detecting
real-time metabolic changes in vivo, which makes it a
sensitive and site-specific method for monitoring metab-
olism in the myocardial interstitial fluid (ISF) during
CA [9]. With this background in mind, we designed
this study to investigate changes of intracardial metabol-
ism measured by microdialysis under different manage-
ment methods in an established porcine model of CA,
and we also sought to determine whether administration
of sildenafil is optimal for attenuating postresuscita-
tion myocardial dysfunction by obtaining extracellular
metabolic evidence.Material and methods
Ethics statement
This study was carried out in strict accordance with
the guidelines for animal care and use established by
the Capital Medical University Animal Care and Use
Committee. The study’s experimental protocol was
approved by the Committee on the Ethics of Animal
Experiments of Capital Medical University (permit
number 2010-D-013). The animals used in this study
were handled in compliance with the Guiding Principles for
the Care and Use of Animals expressed in the Declaration
of Helsinki [10]. All animals were maintained in a specific
pathogen-free environment in our facility and were fed
standard chow and had free access to water. All surgeries
were performed while the animals were under anesthesia
and analgesia, and all efforts were made to minimize
the animals’ suffering.
Animal preparation
Twenty-four inbred male Wuzhishan (WZS) miniature
piglets ages 11 to 13 months with an average weight of
30 ± 2 kg were used in each part of this study. Our
choice of the WZS miniature piglets was based on their
characteristics similar to humans with regard to histologic
structures and physiology, and especially due to the highest
inbreeding coefficient (>0.965) [11]. The piglets were
randomly assigned to one of three groups: a sildenafil
group (n = 8), a saline (SA) group (n = 8) and sham
operation (SHAM) group (n = 8). Sildenafil was obtained
from a 25-mg tablet (Pfizer, West Ryde, Australia) that
was dissolved in 50 ml of saline, filtered and stored at 4°C.
This solution was delivered once intraperitoneally in a
dose of 0.5 mg/kg 30 minutes prior to ventricular fibrilla-
tion (VF) [12]. The drugs were delivered in a randomized
manner by using the sealed envelope method. The vehicle
(0.9% NaCl) was administered in the same manner and
volume. The investigator was blinded to the treatment.
After premedication with 0.5 mg/kg intramuscular
midazolam, anesthesia was induced by ear vein injection
of propofol (1.0 mg/kg) and maintained in a surgical plane
of anesthesia with intravenous infusion of sodium pento-
barbital (8 mg/kg/hr). All animals were intubated with a
cuffed 6.5-mm endotracheal tube and ventilated with a
volume-controlled ventilator (Servo 900C; Siemens,
Munich, Germany) using a tidal volume of 8 ml/kg and a
respiratory frequency of 12 breaths/min on room air.
End-tidal partial pressure of carbon dioxide (pCO2) was
measured by in-line infrared capnograph (CO2SMO plus
capnograph and pulse oximeter monitor; Respironics,
Murrysville, PA, USA). Respiratory frequency was adjusted
to maintain end-tidal pCO2 between 35 and 40 mmHg
before inducing CA. Room temperature was adjusted to
26°C, and body temperature was maintained at 37°C
under an infrared lamp. All efforts were made to minimize
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by infusing 30 ml/kg of acetated Ringer’s solution during
the first hour of preparation, followed by a continuous
infusion of 2.5% glucose electrolyte solution at 8 ml/kg/hr
and acetated Ringer’s solution 20 ml/kg/hr.
An angiographic catheter was inserted from the
femoral artery into the aortic arch for reference blood
samples and for measuring aortic pressure. A Swan-
Ganz catheter (7-French; Edwards Lifesciences, Irvine,
CA, USA) was advanced from the right femoral vein and
flow-directed into the pulmonary artery for measurement
of right atrial pressure, mean pulmonary arterial pressure
(MPAP) and cardiac output (CO). The electrocardiograms
(ECGs) and all hemodynamic parameters were monitored
with a patient monitoring system (M1165; Hewlett-Packard,
Palo Alto, CA, USA).
Experimental protocol
The experimental procedure of cardiopulmonary resuscita-
tion (CPR) was performed as follows (Figure 1). After estab-
lishment of vascular catheter placement, the animals were
allowed to equilibrate for 30 minutes to achieve a stable
resting level. Baseline measurements of arterial blood gases
were obtained. Mechanical ventilation was established as
described above. The temporary pacemaker conductor was
inserted into the right ventricle through the right internal
jugular vein and connected to an electrical stimulator
(GY-600A; Kaifeng Henan Equipment Co, Kaifeng, China)
programmed in the S1/S2 mode (300/200 ms), 40 V, 8:1
proportion and 10-ms step length to provide a continuous
electrical stimulus until VF was achieved [13].
The chest was opened by median strenotomy, and the
heart was suspended in a pericardial cradle. Two pairs of
2-mm piezoelectric transducers were placed on the
endocardial surface of the left ventricle (LV) on the
major and minor axes. A tourniquet was placed around
the inferior vena cava. Heparin sodium (200 U/kg) was
administered intravenously before probe implantation to
prevent blood coagulation [14]. Two microdialysis catheters
(CMA70; CMA Microdialysis AB, Kista, Sweden) were
implanted separately into the lateral wall of the LVFigure 1 Diagram of protocol of the first ventricular fibrillation. Ventricu
connected to an electrical stimulator programmed in the S1/S2 mode (300/20
spontaneous circulation.myocardium midway between the apex and base of
the heart. The CMA70 catheters were perfused with
Ringer’s solution in situ for 45 minutes before baseline
measurements were taken, and a constant flow was
maintained (2.5 μl/min) using a microdialysis pump
(CMA106; Microdialysis AB) [14] (Figure 2). The dialysate
was collected by using a dialysate collector (CMA142;
Microdialysis AB) every 30 minutes. The ISF from the LV
wall was collected through the microdialysis tubes for
10 minutes (baseline). VF was then electrically induced
and continued for 8 minutes. VF was defined as an
electrocardiogram showing waveforms corresponding
to VF and a rapid decline in mean aortic pressure
(MAP) toward zero. Ventilation was stopped during VF
induction, and ventilation was withheld for the entire
8-minute duration of VF. ISF was collected continuously
at 0 to 2, 2 to 4, 4 to 6, and 6 to 8 minutes of VF.
After 8 minutes of untreated VF, open-chest CPR was
started with a compression rate of 60 to 80 times per
minute, because it is almost impossible to have a com-
pression rate higher than 80 per minute without dam-
aging the myocardium while handling the heart. During
CPR, 100% oxygen was delivered with the same baseline
ventilator settings. After 2 minutes of open-chest CPR, an
internal monophasic countershock was delivered at the
energy level of 20 J (Physio-Control, Redmond, WA,
USA). Subsequent defibrillatory shocks were increased
to 40 J, and all subsequent attempts were made at
the 40-J dose [15]. If ROSC was not achieved after six
shocks, a bolus of 0.4 U/kg vasopressin was administered
through the right atrial catheter. CPR was continued for
up to 15 minutes. CPR was discontinued if ROSC was not
achieved during this period.
ROSC was defined as 10 consecutive minutes of
maintenance of systolic blood pressure at 50 mmHg.
If spontaneous circulation was not restored within
30 minutes, we regarded the animal as dead [16]. All the
animals received normal saline (10 ml/kg/hr) intraopera-
tively to replenish fluid losses. Five minutes after ROSC,
oxygen was reset to 30%. Minute ventilation and respiratory
frequency were also maintained accordingly to maintainlar fibrillation (VF) was induced by a temporary pacemaker conductor
0 ms). CPR, Cardiopulmonary resuscitation; ROSC, Restoration of
Figure 2 Schematic representation of a microdialysis probe
implanted into the piglet myocardium.
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PaCO2 within the range of 5.0 kPa to 5.5 kPa if arterial pH
was <7.20. If the base deficit was more than 10 mmol/L
5 minutes after ROSC, acidosis was corrected with a
1 mmol/kg Tris buffer mixture (Tribonat; Kabi Fresenius,
Stockholm, Sweden) and by increasing minute ventilation
[16]. The animals were continuously anesthetized and
underwent a 24-hour intensive care period. With the
exception of a right internal jugular vein sheath that
was used for fluid administration, all other vascular sheaths
were removed 6 hours after ROSC. The anesthetized ani-
mals were constantly monitored and underwent a 24-hour
intensive care period when Ringer’s solution (20 ml/kg/hr)
was administered. Next, the anesthetized piglets were killed
with 10 ml of 10 mol/L potassium chloride intravenously
following a bolus of 100 mg of propofol intravenously
24 hours after ROSC, when the last measurements were
made. Myocardial specimens were snap-frozen in liquid
nitrogen and stored at −80°C.
Measurements
Hemodynamic and oxygen metabolism parameters
collection
ECGs were continuously monitored. The hemodynamic
parameters, including heart rate (HR), CO, MAP and
MPAP, were measured continuously. We recorded the
values at baseline, 30 minutes and 1, 2, 4 and 6 hours
after ROSC. At the end of each time point, 4°C saline
was injected into the right atrium through the Swan-Ganz
catheter to determine CO by the transpulmonary thermo-
dilution method as described previously [16]. MAP was
determined by the electronic integration of the aortic
blood pressure waveform. The amounts of infused
fluid and urine output were also monitored during the
experiment. Serum lactate levels and arterial blood gas
values for which temperatures were corrected to 37°C
were measured regularly using an ABL 520 Blood GasAnalyzer (Radiometer Medical ApS, Bronshoj, Denmark).
Coronary perfusion pressure (CPP) was calculated as the
difference between decompression diastolic aortic and
time-coincident right atrial pressure measured at the end
of each minute of precordial compression. CPP during VF
was defined as the difference between the mean aortic
and mean right atrial pressures. Oxygen metabolism
parameters, including oxygen delivery (DO2) and oxygen
consumption (VO2), were calculated.
Myocardial energy metabolites
After the animals were killed at 24 hours after ROSC,
the hearts were excised, and the right ventricles and
both atria were removed. The myocardium was sampled
from the anterior left ventricular wall starting at the
apex and moving toward the base in a zigzag pattern to
avoid vascular injury that could compromise blood supply
to the region of the subsequent sample. Samples were
immersed in liquid N2 within 10 seconds and then stored
at −80°C and subsequently processed for ADP and ATP
measurement using reversed-phase high-performance
liquid chromatography (System Gold HPLC system
with 32 Karat Software 5.0; Beckman Coulter, Brea, CA,
USA) [17]. The percentage of phosphorylated creatine was
calculated relative to the combined phosphocreatine and
creatine pool. Enzyme activity was assessed by measuring
the optical density of inorganic phosphate decomposed
from ATP by the tissue protein according to the method
of Isbir et al. [18]. Na+-K+-ATPase and Ca2+-ATPase
enzyme activity was determined using standard formulas.
Biochemical parameter analysis in microdialysis
A CMA600 Microdialysis Analyser (CMA Microdialysis
AB) was utilized for the quantitative determination of
glucose, lactate, glutamate, pyruvate and glycerol in
the ISF. All procedures were conducted in adherence
to the manufacturer’s instructions using the original
(manufacturer-supplied) reagent kits and calibrators. The
analytic methods were based on enzymatic colorimetric
assays [19]. All samples were collected in glass vials and
sealed with Chromacol crimp caps (Thermo Scientific,
Waltham, MA, USA) directly after sampling.
Survival
The survival rate was determined based on the animals
that survived the experimental protocol starting at ROSC
until 24 hours after ROSC. Animals that died during
surgical recovery were excluded.
Statistical analysis
The results are expressed as mean ± SD. Student’s t-test
was used for comparisons between every two groups.
Differences at different time points were assessed by
repeated-measures analysis of variance and the Bonferroni
Table 2 Cardiopulmonary resuscitation outcomesa
SA group Sildenafil group P-values
(n = 8) (n = 8)
Number of defibrillatory
shocks
4.31 ± 1.62 2.91 ± 0.83 0.81
Cumulative defibrillation
energy (J)
145.01 ± 33.41 95.02 ± 33.41 <0.001
Duration of CPR before
ROSC (min)
6.12 ± 2.21 4.71 ± 1.32 0.25
6-hour survival 5 7 0.83
24-hour survival 3 7 0.04
aValues are mean ± SD or number (n). CPR, Cardiopulmonary resuscitation;
ROSC, Restoration of spontaneous circulation; SA, Saline.
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experimental groups. In addition, the continuous variables
were fixed to normal distributions and equal variances
were analyzed by using the Kolmogorov-Smirnov test and
homogeneity of variance test. Survival analysis was
performed using the method of Kaplan and Meier,
and comparisons between groups were made using the
logrank test. A P-value <0.05 was considered statistically
significant. All analyses were conducted using SPSS 17.0
software (SPSS, Chicago, IL, USA) and GraphPad Prism
version 6 software (GraphPad Software, La Jolla, CA, USA).
Results
Baseline status
Baseline hemodynamic measurements and oxygen metab-
olism measurements are shown in Table 1. None of the
variables (body weight, HR, MAP, MPAP, CO, lactate
concentration, DO2, VO2 and extraction of oxygen
differed significantly between the three groups (P > 0.05).
Resuscitation outcomes and survival
Resuscitation outcomes are shown in Table 2. None of
the 16 animals achieved ROSC after initial defibrillation
attempts. By comparison, the cumulative defibrillation
energy was significantly lower in the sildenafil group
than in the SA group (P < 0.0001). ROSC was achieved
in all eight piglets in the sildenafil group and in seven of
eight piglets in the SA group. There were no significant
differences in 6-hour survival rate between the two
groups (SA group and sildenafil group) (P = 0.83). In the
SA group, four piglets died at 10 minutes, 189 minutes,
387 minutes and 404 minutes after ROSC, respectively.
In the sildenafil group, only one piglet died at 48 minutes
after ROSC. A significant difference in survival to the end
of the 24-hour experiment period between the sildenafil
and SA groups was demonstrated using the Kaplan-Meier
survival curve and the logrank test (P < 0.05) (Figure 3).Table 1 Baseline characteristicsa
Sham group SA group Sildenafil group
(n = 8) (n = 8) (n = 8)
Weight, kg 29.13 ± 2.16 30.63 ± 0.92 30.38 ± 0.92
HR, beats/min 99.00 ± 7.44 101.38 ± 8.30 100.50 ± 10.04
MAP, mmHg 103.12 ± 5.19 101.88 ± 5.22 87.00 ± 5.81
MPAP, mmHg 23.42 ± 4.32 24.13 ± 5.24 24.34 ± 4.56
CO, L/min 2.86 ± 0.22 2.99 ± 0.20 2.99 ± 0.19
DO2, ml/min 424 ± 35 445 ± 34 450 ± 28
VO2, ml/min 112 ± 12 112 ± 9 115 ± 12
ERO2, % 24.17 ± 2.34 25.44 ± 2.70 25.46 ± 1.49
Lac, mmol/L 1.21 ± 0.49 1.31 ± 0.72 1.23 ± 0.01
aValues are mean ± SD. CO, Cardiac output; DO2, Oxygen delivery; ERO2,
Extraction of oxygen; HR, Heart rate; Lac, Lactate; MAP, Mean aortic pressure;
MPAP, Mean pulmonary arterial pressure; SA, Saline; VO2, Oxygen consumption.Left ventricular function evaluation by invasive
hemodynamic variables and oxygen metabolism status
After ROSC, HR was significantly lower in the sildenafil
group compared with the SA group at 1 and 2 hours
after ROSC (P = 0.04, P = 0.03, respectively); however,
there were no significant differences between the two
groups at any other time points (Figure 4A). The CO
values were significantly higher in the sildenafil group
than in the SA group at 4 hours and 6 hours after ROSC
(P= 0.02, P= 0.04, respectively) (Figure 4B). The MAP and
CPP values were significantly increased in the sildenafil
group compared with the SA group at baseline and
30 minutes after ROSC (P < 0.05 for both) (Figures 4C
and 4D). These values were similar between the groups at
other time points. Notably, MPAP was elevated in the
sildenafil group and the SA group after CA, and the
values of MPAP in the sildenafil group were continuouslyFigure 3 Kaplan-Meier survival curve. We found a significant
difference in survival between the sildenafil group and the saline
group (P < 0.001 by logrank test).
Figure 4 Left ventricular function evaluation based on invasive hemodynamic variables and oxygen metabolism. (A) Heart rate (HR).
(B) Cardiac output (CO). (C) Mean aortic pressure (MAP). (D) Coronary perfusion pressure (CPP). (E) Mean pulmonary arterial pressure (MPAP).
(F) Oxygen delivery (DO2). (G) Oxygen consumption (VO2). (H) Lactate (Lac). The values are reported as mean ± SD. ROSC, restoration of spontaneous
circulation; SA, saline. *P < 0.05 vs. sham, **P < 0.01 vs. sham, ΔP < 0.05 vs. saline (one-way repeated-measures analysis of variance).
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respectively) (Figure 4E). Oxygen metabolism measure-
ments were compared among the three groups. DO2 was
significantly higher in the sildenafil group than in the SA
group at 2, 4 and 6 hours after ROSC (P = 0.03, P = 0.02
and P = 0.04, respectively), and VO2 was significantly
higher in the sildenafil group than in the SA group at
30 minutes and 1, 2, 4 and 6 hours after ROSC (P = 0.02,
P = 0.03, P = 0.007, P = 0.03 and P = 0.04, respectively)
(Figures 4F and 4G). Serum lactate concentrations
were significantly increased throughout the study time
points after ROSC compared with baseline values in
two groups (the SA and sildenafil groups) (P < 0.05)
(Figure 4H). However, the lactate concentrations were
lower in the sildenafil group than in the SA group at
30 minutes and 1 and 2 hours after ROSC (P = 0.02,
P = 0.03, P = 0.01, respectively) (see Additional file 1:
Table S1 for details).
Myocardial energy effects of sildenafil at 24 hours after
ROSC
Myocardial tissue analysis revealed a dramatic increase
in the content of ATP, ADP and phosphocreatine in the
sildenafil group compared with the SA group at 24 hours
after ROSC (P = 0.03, P = 0.02, P = 0.02, respectively)
(Table 3). The activities of left ventricle Na+-K+-ATPase
and Ca2+-ATPase were significantly increased in the
sildenafil group compared with the SA group at 24 hours
after ROSC (P = 0.03, P = 0.04, respectively) (Table 3).
All of these data are consistent with rapid development
of intense myocardial ischemia.
Effect of the sildenafil on myocardial energy metabolites
by microdialysis
The microdialysis probes were implanted and extracted
without inducing arrhythmias or other side effects. Real-
time measurement of myocardial energy metabolic variables
(glucose, pyruvate and glutamate), markers of injury (lactate
and glycerol) and their ratios are presented in Figures 5A to
5E. No differences were noted at baseline between the
groups. The mean ISF glucose levels decreased in all groups
after CA and increased following CPR. The sildenafil groupTable 3 The contents of ATP, ADP, phosphocreatine, Na+-K+-A
at 24 hours after successful resuscitationa
Group Phosphocreatine (nmol/mg protein) ATP (nmol/mg protei
Sham 33.36 ± 7.27 16.49 ± 1.67
SA 19.71 ± 9.41** 10.49 ± 1.08**
Sildenafil 26.43 ± 4.66*† 12.3 ± 1.11*†
aValues are mean ± SD. SA, Saline. *P < 0.05 vs. sham, **P < 0.01 vs. sham, †P < 0.05 v
analysis of variance. All posttests were performed using the Bonferroni method. My
ADP and phosphocreatine in the sildenafil group compared with the SA group at 2
ventricle Na+-K+-ATPase and Ca2+-ATPase were significantly increased in the sildena
P = 0.04, respectively).had a higher glucose level than the SA group during
VF and the early reperfusion phase (P < 0.05) (Figure 5A).
ISF lactate was elevated in all groups after VF, and
the lactate levels rose further to reach a maximum
after 10 minutes of VF and then declined slowly. Lactate
levels in the SA group were continuously higher than in
the other two groups (P < 0.05) (Figure 5B). The pyruvate
levels were reduced significantly in the sildenafil and SA
groups during VF; however, the levels of pyruvate were
higher in the sildenafil group than in the SA group, even
after CPR (Figure 5C). The glycerol level was elevated in
the SA group after VF and stayed at a higher level com-
pared with the other two groups, and the glycerol level of
the sildenafil group also increased after VF and declined
more significantly than in the SA group (Figure 5D).
The lactate-to-pyruvate (L/P) ratios and glutamate
levels in the SA group were dramatically higher than
in the other two groups during and after CA (P < 0.05)
(Figures 5E and 5F). Additional information is available in
Additional file 1: Table S2.
Discussion
We found that pretreatment with sildenafil reduced the
severity of postresuscitation myocardial dysfunction during
the no-flow or low-flow state of CA in this porcine model
of CA. In our analysis of the changes of ISF metabolites
(glucose, lactate, glutamate, pyruvate and glycerol) during
VF and reperfusion, we observed that sildenafil inhibited
abrupt increases in ISF lactate and glutamate levels, which
indicates that sildenafil could improve myocardial energy
metabolism during ischemia and reperfusion.
Although several studies have focused on the role of
PDE5 inhibition on I/R injury in the myocardium [5-7],
this study is, to our knowledge, the first to demonstrate
that pretreatment with sildenafil prior to VF after CA is
cardioprotective. Myocardial I/R injury occurs in a
wide spectrum of patients, ranging from survivors of
out-of-hospital CA to patients who have acute myocardial
infarction and patients undergoing cardiac surgery.
Ockaili et al. conducted the first study showing a
powerful preconditioning-like effect of sildenafil against
myocardial I/R injury in an in vivo rabbit model [20]. TheTPase and Ca2+-ATPase activities in left ventricle tissue
n) ADP (nmol/mg protein) Na+-K+-ATPase (U) Ca2+-ATPase (U)
1.51 ± 0.12 9.21 ± 1.45 10.96 ± 0.94
0.91 ± 0.10** 4.97 ± 1.04** 3.65 ± 1.01**
1.11 ± 0.21*† 6.89 ± 1.37*† 4.58 ± 1.43**†
s. SA. All calculations were performed using one-way repeated-measures
ocardial tissue analysis revealed a dramatic increase in the content of ATP,
4 hours after ROSC (P = 0.03, P = 0.02, P = 0.02, respectively). The activities of left
fil group compared with the SA group at 24 hours after ROSC (P = 0.03,
Figure 5 The myocardial interstitial fluid concentrations of glucose, lactate, pyruvate, glycerol and glutamate as determined by
microdialysis under basal conditions (before ventricular fibrillation) and after ventricular fibrillation. (A) Myocardial interstitial fluid (ISF)
concentrations of glucose. (B) ISF concentrations of lactate (Lac). (C) ISF concentrations of pyruvate. (D): ISF concentrations of glycerol. (E) ISF
concentrations of lactate/pyruvate (Lac/pyr). (F) ISF concentrations of glutamate. The values are reported as mean ± SD. CPR, Cardiopulmonary
resuscitation; ROSC, restoration of spontaneous circulation; VF, Ventricular fibrillation. *P < 0.05 vs. sham, **P < 0.01 vs. sham, ΔP < 0.05 vs. saline
(one-way repeated-measures analysis of variance).
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ventricular arrhythmias were also observed, as well as
improvement of postischemic ventricular contractile func-
tion [21]. In another previous study, researchers demon-
strated that, in an atherosclerotic mice model, sildenafil
reduced oxidative stress and increased NO bioavailability,
which culminated in protection against DNA damage [7].All of these results are in accordance with our findings that
the postresuscitation hemodynamic profile in the sildenafil
group seemed to correspond with a less severe myocardial
injury (higher ATP and Na+-K+-ATPase levels) and less
dysfunction. This may be explained by an enhanced or
better-preserved oxygen supply/demand ratio after suc-
cessful ROSC in the sildenafil group (higher mean aortic
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the 24-hour survival rate showed a promising trend in the
sildenafil group.
The magnitude of cardiac damage observed in piglets in
the present study is similar to the damage observed in
clinical practice (after CA and/or trauma). CA represents
the most severe shock state, during which the delivery of
oxygen and metabolic substrates is abruptly halted and
metabolites are no longer removed [22]. Several studies
have conclusively demonstrated that opening mitochon-
drial ATP-dependent potassium (mito-KATP) channels
plays an important role in ischemic as well as pharmaco-
logical preconditioning in the heart [23]. Opening of the
mito-KATP channel partially compensates for the loss in
membrane potential, which enables additional protons to
be pumped out to form a H+ electrochemical gradient for
both ATP synthesis and Ca2+ transport. In our present
study, we found that the activities of Na+-K+-ATPase and
Ca2+-ATPase were significantly increased in the sildenafil
group compared with the SA group at 24 hours after
ROSC, and we found that the contents of ATP, ADP and
phosphodiesterase in the SA group were much lower than
in the sildenafil group, indicating greater energy exhaus-
tion in the SA group, which indicated that the myocar-
dium energy metabolism system was damaged much
more severely in the SA group than in the sildenafil group.
We therefore suggest that sildenafil may lead to cardiopro-
tection through beneficial effects on energy metabolism by
opening mito-KATP channels. Our results are consistent
with some previous experiments in which administration
of sildenafil was shown to inhibit the breakdown of cGMP
and subsequent high cGMP levels led to acute and delayed
cardioprotection via mito-KATP channel opening and me-
diated preconditioning in rat hearts. These features would
in principle lead to cardioprotection [20].
In vivo microdialysis techniques have made it possible
to directly determine myocardial ISF metabolite changes.
Therefore, in contrast to many previous studies focused
only on serum markers, the findings of the present study
provide comprehensive insight regarding metabolic changes
and cellular energy preservation in ISF during CA by
microdialysis.
The microdialysis results demonstrated real-time changes
of several metabolic markers of basic metabolism in
the ISF. It has been reported that the glucose level in
the dialysate is closely correlated to the oxygen supply
to the mycardium [24]. In the present study, after CA,
glucose concentrations were significantly lower in the
SA and sildenafil groups compared to the sham group
(P < 0.05), whereas the glucose level remained higher in
the sildenafil group than in the SA group during CA and
in the early reperfusion phase. The reason for these effects
is the shift of cellular metabolism to anaerobic conditions,
which causes formation of lactate and an accelerateduptake of extracellular glucose during ischemia to sustain
the energetically inefficient anaerobic glycolysis [25].
Lactate is produced by anaerobic glycolysis when
the metabolic demand for oxygen exceeds the available
oxygen supply [26]. Furthermore, lactate is the end product
of anaerobic metabolism, and pyruvate is the intermediate
product between aerobic and anaerobic metabolism. In
aerobic conditions, pyruvate is produced via glycolysis and
then enters the tricarboxylic acid cycle, largely bypassing
the production of lactate [27]. In our study, the SA group
had the highest lactate level and the lowest pyruvate level
among the groups. Interestingly, compared with the SA
group, sildenafil had almost a lower level of lactate and a
higher level of pyruvate, suggesting that the sildenafil group
had a potent capacity to clear metabolic waste accumulated
in a relatively short CA duration.
The L/P ratio is a more reliable variable than lactate
that characterizes the relationship between aerobic and
anaerobic metabolism [28]. The animals in the SA group
showed rapid deterioration of energy supply with an im-
mediate increase of the L/P ratio as a sign of nutritional
disorder. The L/P ratio in the sildenafil group was lower
than that in the SA group at most time points, which
demonstrated that animals treated with sildenafil had a
better energy reservoir. Nevertheless, the curve of the L/P
ratio for the sildenafil group suggested that sildenafil could
minimize energy depletion to the utmost extent.
Increasing levels of glycerol indicated the degree of de-
struction in the cell membrane [29]. Sildenafil attenuated
the production of glycerol at most time points, which indi-
cates that it had a fair capability to protect myocardial cells.
There are obvious limitations to the design of this study.
First, we acknowledge that our study may lack the power to
detect some additional differences because of a relatively
small sample size. Second, a major limitation is that the ani-
mals were administered sildenafil 30 minutes prior to VF,
which cannot reflect sildenafil’s clinical applicability truly.
Third, it also should be noted that the endpoints of this
study were focused on the acute changes in postresuscita-
tion myocardial dysfunction. The animals were killed
immediately at the end of the study, resulting in a lack of
observation of survival rate changes over a longer time
course. An additional disadvantage of the study is the use
of heparin to avoid hypercoagulability. Heparin may have
impaired thrombus formation and vasoconstriction, which
are physiologic responses in unanesthetized animals. Also,
in the interpretation of our findings, repetitive electrical
shocks themselves may increase the severity of postresusci-
tation myocardial dysfunction in settings of myocardial
ischemia [30]. Further, because our studies were performed
in an animal model in the absence of underlying cardiovas-
cular disease, direct applicability to humans cannot be
assured. Finally, optimal doses and methods of administra-
tion of sildenafil also deserve additional investigation.
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sildenafil in CPR.
Conclusions
On the basis of these experimental studies, we conclude
that the administration of sildenafil increases the success
of initial resuscitation and ameliorates myocardial dys-
function by improving myocardial metabolism. These
findings suggest a critical protective role of sildenafil in
postresuscitation myocardial dysfunction. This study
provides a novel treatment target for protection against
postresuscitation myocardial dysfunction.
Key messages
 Compared with the saline group, the sildenafil group
had better outcomes in terms of hemodynamic and
oxygen metabolism parameters as well as 24-hour
survival rate.
 Sildenafil could reduce the severity of
postresuscitation myocardial dysfunction and
interstitial fluid metabolite changes.
 This work might provide insights into the
development of a novel strategy to treat
postresuscitation myocardial dysfunction.
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